About this webinar

Developed by Dr. Samir Gupta, Michael Boivin and Dr. Vivien Brown, this dynamic presentation covers four key respiratory immunizations (flu, pneumococcal, RSV and COVID-19) and gives attendees up-to-date information on vaccine effectiveness, including on cardiometabolic outcomes, as well as safety profiles and current national recommendations. Beyond the clinical aspects, we touch on the pressing issues of vaccine hesitancy and fatigue, offering evidence-based approaches to overcome these challenges.

Learning Objectives

After attending the session, participants will be able to:

  • Distinguish between RSV, pneumococcal disease, influenza, and COVID-19 in terms of causative agents, transmission, and general epidemiology

  • Interpret the current national recommendations for each vaccine, including target populations and dosing schedules

  • Discuss the vaccine effectiveness (including on cardiometabolic outcomes) and safety to allow for a benefit:risk discussion for vaccination

  • Consider strategies to address vaccine hesitancy in a patient who is a candidate for respiratory vaccines

  • Discuss a multidisciplinary, collaborative approach to increasing respiratory vaccine uptake

About our speakers

Michael Boivin

Pharmacist, medical writer and CME planner · RPh, CDE and CBE

Pharmacist educator from Barrie, Ontario, who has developed over 100 different programs on immunization for healthcare professionals in Canada and other regions of the world.
Michael Boivin

Dr. Vivien Brown

Family Physician · MDCM, CCFP, FCFP and MSCP

An award-winning teacher on many levels, her major areas of interest are health promotion and prevention for women, continuing medical education, adult immunization and vaccine preventable illnesses.
Michael Boivin

Support and Audience

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program (MOC) of The Royal College of Physicians and Surgeons of Canada and approved by the Canadian Thoracic Society. Live webinar participants may claim a maximum of 1 hour.

This webinar is only for healthcare professionals.

This program was co-developed by the Canadian Thoracic Society and RESPIPLUS, and received funding from Pfizer and Merck. It is planned to achieve scientific integrity, objectivity and balance.